Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register

Click here to sign up for SAGE Journal Email Alerts today!

Journal of the Society for Gynecologic Investigation
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Varner, M. W.
Right arrow Articles by Mitchell, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varner, M. W.
Right arrow Articles by Dildy, G. A.
Right arrow Articles by Hunter, C.
Right arrow Articles by Dudley, D. J.
Right arrow Articles by Clark, S. L.
Right arrow Articles by Mitchell, M. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Amniotic Fluid Epidermal Growth Factor Levels in Normal and Abnormal Pregnancies

M. W. Varner, MD

G. A. Dildy, MD

C. Hunter, BS

D. J. Dudley, MD

S. L. Clark, MD

M. D. Mitchell, DSc

Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah; Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand

Objective: To determine the concentrations of epidermal growth factor (EGF) in amniotic fluid (AF) from women during late pregnancy, with and without pathophysiologic complications.

Methods: All AFs were collected by amniocentesis from the following groups: gestational age at least 38 weeks (n = 15); gestational age 36-37 weeks (n = 10); gestational age 35 weeks (n = 5); labor 34 weeks or less, delivered within 7 days (n = 10); labor 34 weeks or less, undelivered (n = 10); chorioamnionitis (n = 7); gestational age-matched controls (n = 7); term, in labor (n = 8); term, not in labor (n = 8); intrauterine growth restriction (IUGR) 38 weeks or more (n = 8); macrosomia at 38 weeks or more (n = 10). Epidermal growth factor was assayed using a specific radioimmunoassay.

Results: Amniotic fluid EGF levels increase rapidly in late pregnancy but are not altered by chorioamnionitis by term or preterm labor. Intrautering growth restriction is associated with lower EGF levels in AF, but macrosomia is without effect.

Conclusions: Epidermal growth factor levels in AF are increased near term and decreased in pregnancies complicated by IUGR; they may be an indicator of specific maturational events.

Key Words: Epidermal growth factor • intrauterine growth restriction • amniotic fluid

Journal of the Society for Gynecologic Investigation, Vol. 3, No. 1, 17-19 (1996)
DOI: 10.1177/107155769600300104


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?